EQUIFAX INC 10-Q

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS The following table contains information with respect to purchases made by or on behalf of Equifax or any “affiliated purchaser” (as defined in Rule 10b-18(a) (3) under the Securities Exchange Act of 1934), of our common stock during our third quarter ended September 30, 2022: Total Number of Shares Average Price Paid Total Number of Shares Purchased as Part of Publicly-Announced Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Period Purchased (1) Per Share (2) Plans or Programs Programs (3) July 1 - July 31, 2022 510 $ — — $ 520,168,924 August 1 - August 31, 2022 2,429 $ — — $ 520,168,924 September 1 - September 30, 2022 549 $ — — $ 520,168,924 Total 3,488 — — 520,168,924 (1) The total number of shares purchased for the quarter includes shares surrendered, or deemed surrendered, in satisfaction of the exercise price and/or to satisfy tax withholding obligations in connection with the exercise of employee stock options, totaling 510 shares for the month of July 2022, 2,429 shares for the month of August 2022, and 549 shares for the month of September 2022. (2) Average price paid per share for shares purchased as part of our share repurchase program (includes brokerage commissions). For the quarter ended September 30, 2022 we did not repurchase any shares of our common stock under our share repurchase program. (3) At September 30, 2022, the amount authorized for future share repurchases under the share repurchase program was $520.2 million. The program does not have a stated expiration date. 40 Dividend and Share Repurchase Restrictions Our Revolver restricts our ability to pay cash dividends on our capital stock or repurchase capital stock if a default or event of default exists or would result if these payments were to occur, according to the terms of the applicable credit agreements. 41 ITEM 6. EXHIBITS Exhibit No. Description 4.1 Tenth Supplemental Indenture, dated as of September 12, 2022, between Equifax Inc. and the Trustee, including the form of Note as Exhibit A (incorporated by reference to Exhibit 4.1 to Equifax's Form 8-K filed September 12, 2022). 10.1 Performance Share Award Agreement (TSR) between Equifax Inc. and Mark Begor under the Equifax Inc. Amended and Restated 2008 Omnibus Incentive Plan (for award granted on July 29, 2022). 10.2 Premium-Priced Stock Option Award Agreement between Equifax Inc. and Mark Begor under the Equifax Inc. Amended and Restated 2008 Omnibus Incentive Plan (for award granted on July 29, 2022). 10.3 Restricted Stock Unit Award Agreement between Equifax Inc. and Mark Begor under the Equifax Inc. Amended and Restated 2008 Omnibus Incentive Plan (for award granted on July 29, 2022). 31.1 Rule 13a-14(a) Certification of Chief Executive Officer 31.2 Rule 13a-14(a) Certification of Chief Financial Officer 32.1 Section 1350 Certification of Chief Executive Officer 32.2 Section 1350 Certification of Chief Financial Officer 101.INS XBRL Instance Document 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase 101.DEF XBRL Taxonomy Extension Definition Linkbase 101.LAB XBRL Taxonomy Extension Label Linkbase 101.PRE XBRL Taxonomy Extension Presentation Linkbase 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) 42 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Equifax Inc. (Registrant) Date: October 20, 2022 By: /s/ Mark W. Begor Mark W. Begor Chief Executive Officer (Principal Executive Officer) Date: October 20, 2022 /s/ John W. Gamble, Jr. John W. Gamble, Jr. Executive Vice President, Chief Financial Officer and Chief Operations Officer (Principal Financial Officer) Date: October 20, 2022 /s/ James M. Griggs James M. Griggs Chief Accounting Officer and Corporate Controller (Principal Accounting Officer) 43